Management of vt vf storm in advanced heart failure

12
Management of VT/VF Storm in Advanced Heart Failure: What to Think About, What Works? What Doesn’t Work? Owen Obel, MD VA North Texas Healthcare System, UT Southwestern Medical Center Dallas, Texas

Transcript of Management of vt vf storm in advanced heart failure

Page 1: Management of vt vf storm in advanced heart failure

Management of VT/VF Storm in

Advanced Heart Failure: What to Think About,

What Works?

What Doesn’t Work?

Owen Obel, MD

VA North Texas Healthcare System, UT

Southwestern Medical Center

Dallas, Texas

Page 2: Management of vt vf storm in advanced heart failure

Disclosures

Speaker: Medtronic, Biotronik, Boston Scientific

Advisory: Medtronic, Biotronik

Page 3: Management of vt vf storm in advanced heart failure

Definition of VT/VF Storm • Diverse arrhythmic

mechanisms, broad

definition

• Frequent episodes of

VT/VF requiring

cardioversion

• Management guidelines

rely on anecdotal evidence

• Most trials define >2

episodes/24h. Episodes

usually more frequent

6 minute recording

Page 4: Management of vt vf storm in advanced heart failure

SUBSTRATE Scar

Myopathy

Hypertrophy

Valve/congenital

Ischemia

Channelopathy

Monomorphic VT

Polymorphic VT

Ventricular Fibrillation

VT/VF Storm Mechanisms

TRIGGER Unknown / 1st shock

Sympathetic hyperactivation

HF decompensation

Ischemia/infarction

Electrolyte (K+ and Mg++)

Ectopy

Special situations

Page 5: Management of vt vf storm in advanced heart failure

VS

ACLS

Guidelines

Group 2 Group 1

OR

VT/VF Storm in Advanced Heart Failure Beta-Blockade

12 patients received all 3

Lidocaine (22)

Procainamide (16)

Bretylium (18)

1 week mortality: 22% group 1 vs. 82% group 2

1 year mortality: 33% group 1 vs. 95% group 2 Nadamanee Circulation 2000

IV beta-

blockers

(21)

Left stellate

ganglion

block (6)

Page 6: Management of vt vf storm in advanced heart failure

• 342 patients with recurrent

VT/VF (BP<80, shock)

• Refractory to/intolerant of:

lidocaine/procainamide/bretylium

• IV Amiodarone:

125mg/24 hr

500mg/24 hr

1000mg/24 hr

• Supplemental infusions for

breakthrough VT

IV Amio Multicenter Trial Group Circulation 1995

VT/VF Storm in Advanced Heart Failure Amiodarone

P=0.067

Amiodarone and beta-blockade

are synergistic

Beta-blockers should always be

co-administered at maximum

tolerated doses

Page 7: Management of vt vf storm in advanced heart failure

Beta-blockade

Amiodarone

Dofetilide

Lidocaine/Mexilitene

✔ Procainamide

Sotalol

Dronedarone

Flecainide

Propafenone

Verapamil/Diltiazem

VT/VF Storm in Advanced

Heart Failure

Page 8: Management of vt vf storm in advanced heart failure

• IV Sedation is used very early in treatment path

• General anesthesia is a highly effective measure

• Propofol reduces sympathetic tone by inhibiting

central sympathetic discharge

• Patients may require >48 hours of full anesthesia

Sedation / General Anesthesia

VT/VF Storm in Advanced Heart Failure When AADs Fail

LV Assist Devices

Cardiac Sympathetic Denervation

Page 9: Management of vt vf storm in advanced heart failure

VT/VF Storm in Advanced Heart Failure LV Assist Devices

IV inotropes for hemodynamic support

are proarrhythmic

LVADs should be used instead

LVADs have a powerful independent

anti-arrhythmic effect (even in DCM)

Page 10: Management of vt vf storm in advanced heart failure

VT/VF Storm in Advanced Heart Failure Cardiac Sympathetic Denervation

Thoracic epidural

anesthesia

Stellate ganglion block/

ganglionectomy

• Both TEA and CSD have been used with success in

VT/VF storm

• Patients with advanced heart failure have been included

in case series

• TEA has more of an immediate effect

• Neither procedure is reported to cause hemodynamic

compromise Vashegi HRJ 2014

Page 11: Management of vt vf storm in advanced heart failure

VT/VF Storm in Advanced Heart Failure CRT-induced Proarrhythmia

Page 12: Management of vt vf storm in advanced heart failure

Conclusions • VT/VF storm is not uncommon in patients with advanced

heart failure, precipitant often not known

• Beta-blockade and amiodarone are the cornerstone AADs

• Sedation (often) or general anesthesia (sometimes)

required

• IV inotropes exacerbate ventricular arrhythmias

• LV assist devices can be of great benefit

• Cardiac sympathetic denervation has been successfully

used